Log In
Print
BCIQ
Print
Print this Print this
 

IV beloranib (ZGN-433)

  Manage Alerts
Collapse Summary General Information
Company Chong Kun Dang Pharmaceutical Corp.
DescriptionIV formulation of a methionine aminopeptidase 2 (MetAP2) inhibitor
Molecular Target Methionine aminopeptidase 2 (MetAP2)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation

Partner

Zafgen Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today